Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer

ClinicalTrials.gov ID: NCT03915951

Public ClinicalTrials.gov record NCT03915951. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 2:53 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an open-label, multicenter, non-randomized, Phase 2 study to determine the safety, tolerability and efficacy of encorafenib given in combination with binimetinib in patients with BRAFV600E-mutant metastatic non-small cell lung cancer (NSCLC). Patients who are either treatment-naïve, OR who have received 1) first-line treatment with standard platinum-based chemotherapy, OR 2) first-line treatment with an anti-programmed cell death protein 1 (PD-1)/programmed cell death protein ligand 1 (PD-L1) inhibitor given alone or in combination with platinum-based chemotherapy will be enrolled.

Study identification

NCT ID
NCT03915951
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
98 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 4, 2019 (Actual)
Primary completion
Sep 22, 2022 (Actual)
Completion
Oct 3, 2025 (Actual)
Last update posted
Mar 24, 2026

2019 – 2025

United States locations

U.S. sites
112
U.S. states
18
U.S. cities
64
Facility City State ZIP Site status
Yuma Regional Medical Center Cancer Center Yuma Arizona 85364 —
Yuma Regional Medical Center Ophthalmology Yuma Arizona 85364 —
Yuma Regional Medical Center Yuma Arizona 85364 —
UCLA Hematology/Oncology Los Angeles California 90095 —
UCLA Stein Eye Center Santa Monica (OPH) Santa Monica California 90403 —
UCLA Hematology/Oncology Santa Monica California 90404 —
Florida Cancer Specialist Altamonte Springs Florida 32701 —
Florida Cancer Specialists Bonita Springs Florida 34135 —
Florida Cancer Specialist Brandon Florida 33511 —
Florida Cancer Specialists Cape Coral Florida 33909 —
Florida Cancer Specialist Clearwater Florida 33761 —
Florida Cancer Specialists Fleming Island Florida 32003 —
Florida Cancer Specialists Fort Myers Florida 33901 —
Florida Cancer Specialists Fort Myers Florida 33905 —
Florida Cancer Specialists Fort Myers Florida 33908 —
Florida Cancer Specialists Fort Myers Florida 33916 —
Florida Cancer Specialist Gainesville Florida 32605 —
Florida Cancer Specialists Largo Florida 33770 —
Florida Cancer Specialist Lecanto Florida 34461 —
Florida Cancer Specialists Naples Florida 34102 —
Florida Cancer Specialist Ocala Florida 34474 —
Florida Cancer Specialist Orange City Florida 32763 —
Florida Cancer Specialist Orlando Florida 32806 —
Florida Cancer Specialists Port Charlotte Florida 33980 —
Florida Cancer Specialists Sarasota Florida 34232 —
Florida Cancer Specialists Sarasota Florida 34236 —
Florida Cancer Specialists Spring Hill Florida 34608 —
Florida Cancer Specialist St. Petersburg Florida 33705 —
Florida Cancer Specialists PAN - SCRI - PPDS Tallahassee Florida 32308 —
Florida Cancer Specialist Tampa Florida 33607 —
Florida Cancer Specialist Tavares Florida 32778 —
Florida Cancer Specialist The Villages Florida 32159 —
Florida Cancer Specialist Trinity Florida 34655 —
Florida Cancer Specialists Venice Florida 34285 —
Florida Cancer Specialists Venice Florida 34292 —
Florida Cancer Specialists Winter Park Florida 32792 —
Winship Cancer Institute @ Emory University Hospital Midtown Atlanta Georgia 30308 —
Emory University Hospital Atlanta Georgia 30322 —
Winship Cancer Institute, Emory University Atlanta Georgia 30322 —
Winship Cancer Institute @ Emory Saint Joseph's Hospital Atlanta Georgia 30342 —
Winship Cancer Institute @ Emory Johns Creek Hospital Johns Creek Georgia 30097 —
Memorial Hospital Shiloh Illinois 62269 —
Siteman Cancer Center - Shiloh Shiloh Illinois 62269 —
MidAmerica Division, Inc. c/o Menorah Medical Center Overland Park Kansas 66209 —
Johns Hopkins Bayview Medical Center Baltimore Maryland 21224 —
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore Maryland 21231 —
The Johns Hopkins Wilmer Eye Institute Baltimore Maryland 21287 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Ophthalmic Consultants of Boston (OCB) Boston Massachusetts 02114 —
Ophthalmic Consultants of Boston Inc Boston Massachusetts 02114 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
Dana Farber / Partners Cancer Care Boston Massachusetts 02115 —
Dana Farber Cancer Institute Boston Massachusetts 02115 —
Beth Israel Deaconess Medical Center/East Boston Massachusetts 02215 —
Dana Farber Cancer Institute Boston Massachusetts 02215 —
Dana-Farber Cancer Institute - Chestnut Hill Newton Massachusetts 02459 —
Siteman Cancer Center - St Peters City of Saint Peters Missouri 63376 —
Siteman Cancer Center - West County Creve Coeur Missouri 63141 —
MidAmerica Division, Inc. c/o Centerpoint Medical Center Independence Missouri 64057 —
MidAmerica Division, Inc., c/o Research Medical Center Kansas City Missouri 64132 —
Siteman Cancer Center St Louis Missouri 63108 —
Barnes-Jewish Hospital St Louis Missouri 63110 —
Saint Louis Children's Hospital St Louis Missouri 63110 —
Washington University School of Medicine St Louis Missouri 63110 —
Washington University St Louis Missouri 63110 —
Siteman Cancer Center - South County St Louis Missouri 63129 —
Memorial Sloan Kettering Cancer Center Basking Ridge Basking Ridge New Jersey 07920 —
Hackensack University Medical Center Edison New Jersey 08837 —
Hackensack University Medical Center Hackensack New Jersey 07601 —
Regional Cancer Care Associates, LLC Hackensack New Jersey 07601 —
Metropolitan Eye Care Paramus New Jersey 07652 —
Memorial Sloan Kettering Cancer Center David H Koch Center for Cancer Care New York New York 10021 —
Weill Cornell Eye Associates New York New York 10021 —
Weill Cornell Medical College - New York Presbyterian Hospital New York New York 10021 —
Memorial Sloan Kettering Cancer Center New York New York 10065 —
Weill Cornell Medical College - New York Presbyterian Hospital New York New York 10065 —
Duke Cancer Center Durham North Carolina 27710 —
Ohio State CarePoint East Columbus Ohio 43203 —
The Ohio State University East Hospital Columbus Ohio 43203 —
The Ohio State University Hospital Columbus Ohio 43210 —
The Ohio State University James Cancer Hospital Columbus Ohio 43210 —
The Ohio State University Medical Center - Thoracic Oncology Clinic Columbus Ohio 43210 —
Ohio State Eye and Ear Institute Columbus Ohio 43212 —
Stefanie Spielman Comprehensive Breast Cancer Columbus Ohio 43212 —
Martha Morehouse Medical Plaza Columbus Ohio 43221 —
Ohio State CarePoint Gahanna Gahanna Ohio 43230 —
Ohio State Outpatient Care Lewis Center Lewis Center Ohio 43035 —
The Ohio State University East Hospital Ohio State Outpatient Care New Albany Westerville Ohio 43081 —
Providence Cancer Institute Clackamas Clinic Clackamas Oregon 97015 —
Providence Cancer Institute Newberg Clinic Newberg Oregon 97132 —
Providence Cancer Institute, Franz Clinic Portland Oregon 97213 —
Providence Oncology and Hematology Care Clinic - Westside Portland Oregon 97225 —
UPMC Hillman Cancer Center Erie Erie Pennsylvania 16505 —
UPMC Hillman Cancer Center - Arnold Palmer - Mt View Greensburg Pennsylvania 15601 —
UPMC Hillman Cancer Center Monroeville Monroeville Pennsylvania 15146 —
UPMC Eye Center, Eye and Ear Institute Pittsburgh Pennsylvania 15213 —
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15232 —
UPMC Hillman Cancer Center - Passavant (HOA) Pittsburgh Pennsylvania 15237 —
UPMC Hillman Cancer Center - Passavant (OHA) Pittsburgh Pennsylvania 15237 —
UPMC Hillman Cancer Center - Upper St. Clair Pittsburgh Pennsylvania 15243 —
Weaver Eye Associates York Pennsylvania 17402 —
WellSpan Health York Pennsylvania 17403 —
WellSpan Oncology Research York Pennsylvania 17403 —
Tennessee Oncology, PLLC Chattanooga Tennessee 37404 —
Tennessee Oncology, PLLC Cleveland Tennessee 37311 —
Tennessee Oncology, PLLC Nashville Tennessee 37203 —
Tennessee Oncology, PLLC Shelbyville Tennessee 37160 —
Houston Eye Associates - Gramercy Location Houston Texas 77008 —
The University of Texas MD Anderson Cancer Center Houston Texas 77030 —
Millennium Research & Clinical Development Houston Texas 77090 —
Eye associates Northwest Seattle Washington 98104 —
Seattle Cancer Care Alliance Seattle Washington 98109 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03915951, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 24, 2026 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03915951 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →